These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 29088026)

  • 1. Impact of National Ten-Valent Pneumococcal Conjugate Vaccine Program on Reducing Antimicrobial Use and Tympanostomy Tube Placements in Finland.
    Palmu AA; Rinta-Kokko H; Nohynek H; Nuorti JP; Jokinen J
    Pediatr Infect Dis J; 2018 Jan; 37(1):97-102. PubMed ID: 29088026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indirect Impact of Ten-valent Pneumococcal Conjugate Vaccine Program on Reducing Antimicrobial Use and Tympanostomy Tube Placements in Finland.
    Palmu AA; Rinta-Kokko H; Nohynek H; Nuorti JP
    Pediatr Infect Dis J; 2020 Sep; 39(9):862-866. PubMed ID: 32412982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term impact of 10-valent pneumococcal conjugate vaccination on invasive pneumococcal disease among children in Finland.
    Rinta-Kokko H; Palmu AA; Auranen K; Nuorti JP; Toropainen M; Siira L; Virtanen MJ; Nohynek H; Jokinen J
    Vaccine; 2018 Apr; 36(15):1934-1940. PubMed ID: 29526371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of ten-valent pneumococcal conjugate vaccine on pneumonia in Finnish children in a nation-wide population-based study.
    Palmu AA; Rinta-Kokko H; Nohynek H; Nuorti JP; Kilpi TM; Jokinen J
    PLoS One; 2017; 12(3):e0172690. PubMed ID: 28249015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the 10-valent pneumococcal conjugate vaccine on antimicrobial prescriptions in young children: a whole population study.
    Eythorsson E; Sigurdsson S; Hrafnkelsson B; Erlendsdóttir H; Haraldsson Á; Kristinsson KG
    BMC Infect Dis; 2018 Oct; 18(1):505. PubMed ID: 30286726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) on outpatient antimicrobial purchases: a double-blind, cluster randomised phase 3-4 trial.
    Palmu AA; Jokinen J; Nieminen H; Rinta-Kokko H; Ruokokoski E; Puumalainen T; Borys D; Lommel P; Traskine M; Moreira M; Schuerman L; Kilpi TM
    Lancet Infect Dis; 2014 Mar; 14(3):205-12. PubMed ID: 24287186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pneumococcal Conjugate Vaccine and Clinically Suspected Invasive Pneumococcal Disease.
    Palmu AA; Kilpi TM; Rinta-Kokko H; Nohynek H; Toropainen M; Nuorti JP; Jokinen J
    Pediatrics; 2015 Jul; 136(1):e22-7. PubMed ID: 26077477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of the Ten-valent Pneumococcal Conjugate Vaccine Against Tympanostomy Tube Placements in a Cluster-randomized Trial.
    Palmu AA; Jokinen J; Nieminen H; Rinta-Kokko H; Ruokokoski E; Puumalainen T; Traskine M; Moreira M; Borys D; Schuerman L; Kilpi TM
    Pediatr Infect Dis J; 2015 Nov; 34(11):1230-5. PubMed ID: 26284652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccine-preventable disease incidence of pneumococcal conjugate vaccine in the Finnish invasive pneumococcal disease vaccine trial.
    Palmu AA; Jokinen J; Nieminen H; Rinta-Kokko H; Ruokokoski E; Puumalainen T; Moreira M; Schuerman L; Borys D; Kilpi TM
    Vaccine; 2018 Mar; 36(14):1816-1822. PubMed ID: 29503110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increase in tympanostomy tube placements despite pneumococcal vaccination, a population-based study.
    Eythorsson E; Sigurdsson S; Erlendsdóttir H; Hrafnkelsson B; Kristinsson KG; Haraldsson Á
    Acta Paediatr; 2019 Aug; 108(8):1527-1534. PubMed ID: 30667099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The seven-valent pneumococcal conjugate vaccine reduces tympanostomy tube placement in children.
    Palmu AA; Verho J; Jokinen J; Karma P; Kilpi TM
    Pediatr Infect Dis J; 2004 Aug; 23(8):732-8. PubMed ID: 15295223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in Otitis Media Incidence After Conjugate Pneumococcal Vaccination: A National Observational Study.
    Gisselsson-Solen M
    Pediatr Infect Dis J; 2017 Nov; 36(11):1027-1031. PubMed ID: 28657970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of frequent otitis media and pressure-equalizing tube insertions in children after introduction of pneumococcal conjugate vaccine.
    Poehling KA; Szilagyi PG; Grijalva CG; Martin SW; LaFleur B; Mitchel E; Barth RD; Nuorti JP; Griffin MR
    Pediatrics; 2007 Apr; 119(4):707-15. PubMed ID: 17403841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term effect of pneumococcal conjugate vaccines on tympanostomy tube placements.
    Sarasoja I; Jokinen J; Lahdenkari M; Kilpi T; Palmu AA
    Pediatr Infect Dis J; 2013 May; 32(5):517-20. PubMed ID: 23190780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Register-Based Ecologic Evaluation of Safety Signals Related to Pneumococcal Conjugate Vaccine in Children.
    Artama M; Rinta-Kokko H; Nohynek H; Jokinen J; Palmu AA
    Curr Drug Saf; 2018; 13(2):107-112. PubMed ID: 29623819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in acute otitis media-related health care utilization by privately insured young children in the United States, 1997-2004.
    Zhou F; Shefer A; Kong Y; Nuorti JP
    Pediatrics; 2008 Feb; 121(2):253-60. PubMed ID: 18245415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccine effectiveness of the pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against clinically suspected invasive pneumococcal disease: a cluster-randomised trial.
    Palmu AA; Jokinen J; Nieminen H; Syrjänen R; Ruokokoski E; Puumalainen T; Moreira M; Schuerman L; Borys D; Kilpi TM
    Lancet Respir Med; 2014 Sep; 2(9):717-27. PubMed ID: 25127244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pneumococcal conjugate vaccination in children with recurrent acute otitis media: a therapeutic alternative?
    van Kempen MJ; Vermeiren JS; Vaneechoutte M; Claeys G; Veenhoven RH; Rijkers GT; Sanders EA; Dhooge IJ
    Int J Pediatr Otorhinolaryngol; 2006 Feb; 70(2):275-85. PubMed ID: 16140397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of a 10- versus 13-valent pneumococcal conjugate vaccine in Denmark and Sweden.
    Klok RM; Lindkvist RM; Ekelund M; Farkouh RA; Strutton DR
    Clin Ther; 2013 Feb; 35(2):119-34. PubMed ID: 23312274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New vaccines against otitis media: projected benefits and cost-effectiveness.
    O'Brien MA; Prosser LA; Paradise JL; Ray GT; Kulldorff M; Kurs-Lasky M; Hinrichsen VL; Mehta J; Colborn DK; Lieu TA
    Pediatrics; 2009 Jun; 123(6):1452-63. PubMed ID: 19482754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.